Bayer trumpets $1bn CRISPR deal with Mammoth BioBayer has bolstered its cell and gene therapy platform by securing access to a CRISPR-based gene-editing platform developed Share XBayer trumpets $1bn CRISPR deal with Mammoth Biohttps://pharmaphorum.com/news/bayer-trumpets-crispr-deal-mammoth-bio/
